Sinopharm for boys: The ANMAT authorized the use of this vaccine for children from 3 to 11 years old | There are 10 million doses reserved for this age group
The Minister of Health of the Nation, Carla Vizzotti, announced this Friday that the National Administration of Medicines, Food and Medical Technology (ANMAT) authorized the emergency use of the Chinese Sinopharm vaccine against COVID-19 in children between three and 11 years old. “They confirmed to us from the ANMAT that we can advance in the … Read more